[EN] TREATMENT FOR LIVER REGENERATION<br/>[FR] TRAITEMENT DE RÉGÉNÉRATION DU FOIE
                        
                            
                                申请人:XENEXUS PHARMACEUTICALS PTY LTD
                            
                            
                                公开号:WO2020014726A1
                            
                            
                                公开(公告)日:2020-01-23
                            
                            Disclosed are pharmaceutical compositions comprising rebamipide together with one or more pharmaceutically acceptable carriers, diluents and excipients. Methods for use of the said compositions for increasing liver regeneration after partial hepatectomy and following liver transplantation to prevent postoperative liver failure and in the treatment of acute and chronic lilver failure are also disclosed.